RNA interfering molecule delivery from in situ forming biodegradable hydrogels for enhancement of bone formation in rat calvarial bone defects
Source abstract
Abstract
RNA interference (RNAi) may be an effective and valuable tool for promoting the growth of functional tissue, as short interfering RNA (siRNA) and microRNA (miRNA) can block the expression of genes that have negative effects on tissue regeneration. Our group has recently reported that the localized and sustained presentation of siRNA against noggin (siNoggin) and miRNA-20a from in situ forming poly(ethylene glycol) (PEG) hydrogels enhanced osteogenic differentiation of encapsulated human bone marrow-derived mesenchymal stem cells (hMSCs). Here, the capacity of the hydrogel system to accelerate bone formation in a rat calvarial bone defect model is presented. After 12 weeks post-implantation, the hydrogels containing encapsulated hMSCs and miRNA-20a resulted in more bone formation in the defects than the hydrogels containing hMSCs without siRNA or with negative control siRNA. This localized and sustained RNA interfering molecule delivery system may provide an excellent platform for healing bony defects and other tissues. Statement of significance Delivery of RNAi molecules may be a valuable strategy to guide cell behavior for tissue engineering applications, but to date there have been no reports of a biomaterial system capable of both encapsulation of cells and controlled delivery of incorporated RNA. Here, we present PEG hydrogels that form in situ via Michael type reaction, and that permit encapsulation of hMSCs and the concomitant controlled delivery of siNoggin and/or miRNA-20a. These RNAs were chosen to suppress noggin, a BMP-2 antagonist, and/or PPAR-γ, a negative regulator of BMP-2-mediated osteogenesis, and therefore promote osteogenic differentiation of hMSCs and subsequent bone repair in critical-sized rat calvarial defects. Simultaneous delivery of hMSCs and miRNA-20a enhanced repair of these defects compared to hydrogels containing hMSCs without siRNA or with negative control siRNA. This in situ forming PEG hydrogel system offers an exciting platform for healing critical-sized bone defects by localized, controlled delivery of RNAi molecules to encapsulated hMSCs and surrounding cells.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Hydrogels: synthesis, properties, applications · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (68)
Show source-provided references
1. Evaluation of bone regeneration using the rat critical size calvarial defect10.1038/nprot.2012.113 ↗
2. Bioactive and osteoinductive bone graft substitutes: definitions, facts and myths10.1016/j.injury.2011.06.010 ↗
3. Synthetic bone graft substitutes10.1046/j.1440-1622.2001.02128.x ↗
4. Bioactive and osteoinductive bone graft substitutes: definitions, facts and myths, Injury 42
5. Orthopaedic applications of bone graft & graft substitutes : a review
6. Bone grafts and bone induction substitutes10.1016/S0094-1298(20)30721-5 ↗
7. Cell-based bone tissue engineering10.1371/journal.pmed.0040009 ↗
8. Hydrogel-β-TCP scaffolds and stem cells for tissue engineering bone10.1016/j.bone.2005.10.016 ↗
9. A combination of biphasic calcium phosphate scaffold with hyaluronic acid-gelatin hydrogel as a new tool for bone regeneration10.1089/ten.tea.2013.0352 ↗
10. In-situ formation of growth-factor-loaded coacervate microparticle-embedded hydrogels for directing encapsulated stem cell fate10.1002/adma.201405337 ↗
11. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase10.1074/jbc.275.13.9645 ↗
12. Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration10.1007/s10856-010-4150-1 ↗
13. Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds10.1016/j.biomaterials.2012.10.005 ↗
14. In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin10.1007/s10856-006-0181-z ↗
15. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned10.1016/j.spinee.2011.04.023 ↗
16. Scaffolds for growth factor delivery as applied to bone tissue engineering10.1155/2012/174942 ↗
17. Bone morphogenetic protein-2 plasmid DNA as a substitute for bone morphogenetic protein-2 protein in bone tissue engineering10.1089/ten.tea.2012.0569 ↗
18. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4)10.1038/sj.gt.3302439 ↗
19. Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells10.1186/ar2436 ↗
20. Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation10.1016/j.biomaterials.2014.04.048 ↗
21. Bone regeneration in rats with BMP-4 and VEGF plasmid DNA10.1016/j.otohns.2004.06.172 ↗
22. Synthetic DNA delivery systems10.1038/71889 ↗
23. Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy10.1517/14712598.2015.1057563 ↗
24. Localized, targeted, and sustained siRNA delivery10.1002/chem.201003144 ↗
25. PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints10.1016/j.ejpb.2012.07.021 ↗
26. Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo10.1002/adma.201303520 ↗
27. Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications10.1016/j.biomaterials.2011.04.065 ↗
28. RNA interference by nanofiber-based siRNA delivery system10.1016/j.jconrel.2010.02.003 ↗
29. Functionalized, biodegradable hydrogels for control over sustained and localized siRNA delivery to incorporated and surrounding cells10.1016/j.actbio.2012.08.012 ↗
30. Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels10.1021/ja9037615 ↗
31. Spatial control of cell gene expression by siRNA gradients in biodegradable hydrogels10.1002/adhm.201400458 ↗
32. Chitosan hydrogel for localized gene silencing10.4161/cbt.11.9.15185 ↗
33. The bone morphogenetic proteins antagonist Noggin inhibits membranous ossification10.1359/jbmr.2001.16.3.497 ↗
34. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling10.4161/rna.8.5.16043 ↗
35. The promotion of bone regeneration through positive regulation of angiogenic–osteogenic coupling using microRNA-26a10.1016/j.biomaterials.2013.03.052 ↗
36. Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing10.1016/j.biomaterials.2017.06.001 ↗
37. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation10.1016/j.biomaterials.2011.08.026 ↗
38. Cell-free 3D scaffold with two-stage delivery of miRNA-26a to regenerate critical-sized bone defects10.1038/ncomms10376 ↗
39. Injectable matrices and scaffolds for drug delivery in tissue engineering10.1016/j.addr.2007.03.013 ↗
40. A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro10.1016/S0169-6009(08)80187-0 ↗
41. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method10.1006/meth.2001.1262 ↗
42. Guidelines for assessment of bone microstructure in rodents using micro–computed tomography10.1002/jbmr.141 ↗
43. The influence of the RGD peptide motif and its contextual presentation in PEG gels on human mesenchymal stem cell viability10.1002/term.95 ↗
44. Photofunctionalization of alginate hydrogels to promote adhesion and proliferation of human mesenchymal stem cells10.1089/ten.tea.2012.0581 ↗
45. Photocrosslinkable, biodegradable hydrogels with controlled cell adhesivity for prolonged siRNA delivery to hMSCs to enhance their osteogenic differentiation10.1039/C6TB01739H ↗
46. Simultaneous delivery of hydrophobic small molecules and siRNA using Sterosomes to direct mesenchymal stem cell differentiation for bone repair10.1016/j.actbio.2017.05.057 ↗
47. Employing the biology of successful fracture repair to heal critical size bone defects
48. Matrix elasticity of void-forming hydrogels controls transplanted-stem-cell-mediated bone formation10.1038/nmat4407 ↗
49. Injectable in situ-forming pH/thermo-sensitive hydrogel for bone tissue engineering10.1089/ten.tea.2007.0407 ↗
50. Nucleophile-initiated thiol-michael reactions: effect of organocatalyst10.1021/ma101069c ↗
51. Hydrolytically degradable Poly(Ethylene Glycol) hydrogel scaffolds with tunable degradation and mechanical properties10.1021/bm100137q ↗
52. Characterization of protein release from hydrolytically degradable poly(ethylene glycol) hydrogels10.1002/bit.22911 ↗
53. An injectable thiol-acrylate poly(ethylene glycol) hydrogel for sustained release of methylprednisolone sodium succinate10.1016/j.biomaterials.2010.08.106 ↗
54. Hydrogels for biomedical applications10.1016/S0169-409X(01)00239-3 ↗
55. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering10.1016/S0142-9612(02)00176-X ↗
56. Inkjet-bioprinted acrylated peptides and PEG hydrogel with human mesenchymal stem cells promote robust bone and cartilage formation with minimal printhead clogging10.1002/biot.201400635 ↗
57. Delivery of siRNA via cationic Sterosomes to enhance osteogenic differentiation of mesenchymal stem cells10.1016/j.jconrel.2015.08.031 ↗
58. The spemann organizer signal noggin binds and inactivates bone morphogenetic protein 410.1016/S0092-8674(00)80133-6 ↗
59. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation10.1074/jbc.M703282200 ↗
60. RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro10.1007/s00774-009-0054-x ↗
61. Light-triggered RNA release and induction of hMSC osteogenesis via photodegradable, dual-crosslinked hydrogels10.2217/nnm-2016-0088 ↗
62. Cytocompatible catalyst-free photodegradable hydrogels for light-mediated RNA release to induce hMSC osteogenesis10.1021/acsbiomaterials.6b00796 ↗
63. Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells In Vitro10.1002/jcb.24240 ↗
64. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts10.1172/JCI3459 ↗
65. Differences between in vitro viability and differentiation and in vivo bone-forming efficacy of human mesenchymal stem cells cultured on PCL–TCP scaffolds10.1016/j.biomaterials.2010.07.001 ↗
66. A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model10.1089/ten.tea.2011.0537 ↗
67. Characterization of protein release from photocrosslinkable hyaluronic acid-polyethylene glycol hydrogel tissue engineering scaffolds10.1016/j.biomaterials.2004.02.018 ↗
68. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels10.1016/j.jconrel.2011.06.027 ↗